- Home
- FBGL vs BFRI Comparison
FBGL vs BFRI Comparison
Compare FBGL & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBGL
- BFRI
- Stock Information
- Founded
- FBGL 1996
- BFRI 1997
- Country
- FBGL Singapore
- BFRI United States
- Employees
- FBGL N/A
- BFRI N/A
- Industry
- FBGL Miscellaneous manufacturing industries
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- FBGL Consumer Discretionary
- BFRI Health Care
- Exchange
- FBGL Nasdaq
- BFRI Nasdaq
- Market Cap
- FBGL 8.1M
- BFRI 7.5M
- IPO Year
- FBGL 2025
- BFRI 2021
- Fundamental
- Price
- FBGL $0.62
- BFRI $0.70
- Analyst Decision
- FBGL
- BFRI Strong Buy
- Analyst Count
- FBGL 0
- BFRI 1
- Target Price
- FBGL N/A
- BFRI $7.00
- AVG Volume (30 Days)
- FBGL 360.1K
- BFRI 83.1K
- Earning Date
- FBGL 01-01-0001
- BFRI 05-15-2025
- Dividend Yield
- FBGL N/A
- BFRI N/A
- EPS Growth
- FBGL N/A
- BFRI N/A
- EPS
- FBGL 0.04
- BFRI N/A
- Revenue
- FBGL $15,607,369.00
- BFRI $37,321,000.00
- Revenue This Year
- FBGL N/A
- BFRI $18.57
- Revenue Next Year
- FBGL N/A
- BFRI $20.17
- P/E Ratio
- FBGL $18.50
- BFRI N/A
- Revenue Growth
- FBGL 25.78
- BFRI 9.54
- 52 Week Low
- FBGL $0.44
- BFRI $0.65
- 52 Week High
- FBGL $5.45
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- FBGL N/A
- BFRI 42.06
- Support Level
- FBGL N/A
- BFRI $0.66
- Resistance Level
- FBGL N/A
- BFRI $0.74
- Average True Range (ATR)
- FBGL 0.00
- BFRI 0.06
- MACD
- FBGL 0.00
- BFRI 0.00
- Stochastic Oscillator
- FBGL 0.00
- BFRI 24.27
About FBGL FBS Global Limited Ordinary Shares
FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial and industrial building projects. As a green contractor focused on environmentally sound practices, It aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, lead lining, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts, sales of construction materials, and rendering of services.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.